Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Surem TRAF3IP2 Level and Atherosclerotic Plaque Development in Human

NCT05945394 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT05945394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05945394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Surem TRAF3IP2 Level and Atherosclerotic Plaque Development in Human
Lead sponsor
Nanjing Medical University
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2023
Completion date
December 31, 2023
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease, susceptibility to, 1